Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus von Mawatari, Seiichi, Kumagai, Kotaro, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Fujisaki, Kunio, Tashima, Shuzo, Inada, Yukiko, Uto, Hirofumi, Saisyoji, Akiko, Hiramine, Yasunari, Hashiguchi, Masafumi, Tamai, Tsutomu, Hori, Takeshi, Taniyama, Ohki, Toyodome, Ai, Sakae, Haruka, Kure, Takeshi, Sakurai, Kazuhiro, Moriuchi, Akihiro, Kanmura, Shuji, Ido, Akio

Volltext

Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus von Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kunio Fujisaki, Shuzo Tashima, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Ohki Taniyama, Ai Toyodome, Haruka Sakae, Takeshi Kure, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido

Volltext

SAT-247-The evaluation of the inhibitory effect of oral anti-hepatitis C virus agents on carcinogenesis von Mawatari, Seiichi, Moriuchi, Akihiro, Tashima, Shuzo, Kasai, Ai, Ijuin, Sho, Tabu, Kazuaki, Oda, Kohei, Ido, Akio

Volltext

Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b von Taniyama, Ohki, Mawatari, Seiichi, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Kumagai, Kotaro, Kasai, Ai, Tashima, Shuzo, Tamai, Tsutomu, Moriuchi, Akihiro, Ido, Akio

Volltext

Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b von Taniyama, Ohki, Mawatari, Seiichi, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Kumagai, Kotaro, Kasai, Ai, Tashima, Shuzo, Tamai, Tsutomu, Moriuchi, Akihiro, Ido, Akio

Volltext